Immunity to 60 kDa heat shock protein in autoimmune diabetes

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 9, Issue 4, 1996, Pages 229-232

  Cohen, I R ^a   Elias, D ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

cells; Antigens; Autoimmunity; Hsp60; Insulin dependent diabetes mellitus; T cells

Indexed keywords

HEAT SHOCK PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; ETIOLOGY; IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029828854     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Elias D., Cohen I.R., Shechter Y., Spirer Z., Golander A.: Antibodies to insulin receptor followed by anti-idiotype antibodies to insulin in a child with hypoglycemia. Diabetes 36: 348-354, 1987.
2. Elias D., Bone A J., Baird J.D., Cooke A., Cohen I.R.: Insulin-mimicking anti-idiotypic antibodies in the development of spontaneous autoimmune diabetes in BB/E rats. Diabetes 39: 1467-1471, 1990.
3. Shechter Y., Maron R., Elias D., Cohen I.R.: Autoantibodies to the insulin receptor spontaneously arise as anti-idiotypes in mice immunized with insulin. Science 216: 542-545, 1982.
4. Shechter Y., Elias D., Maron R., Cohen I.R.: Mouse antibodies to the insulin receptor developing spontaneously as anti-idiotypes. I. Characterization of the antibodies. J. Biol. Chem. 259: 6411-6415, 1984.
5. Elias D., Maron R., Cohen I.R., Shechter Y.: Mouse antibodies to the insulin receptor developing spontaneously as anti-idiotypes. II. Effects on glucose homeostasis and the insulin receptor. J Biol. Chem. 259: 6416-6419, 1984.
6. Van Eden W., Thole J.E.R , Van Der Zee R., Noordzij A., Embden J.D.A., Hensen E.J . Cohen I.R.: Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 331: 171-173, 1988.
7. Cohen I.R.: Autoimmumty to chaperonins in the pathogenesis of arthritis and diabetes. Annu. Rev. Immunol. 9: 567-89, 1991.
8. Elias D., Markovits D., Reshef T., van der Zee R., Cohen I.R.: Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 87: 1576-1580, 1990.
9. Elias D.I. The NOD mouse: A model for autoimmune insulin-dependent diabetes. In: Cohen I.R., Miller A. (Eds), Autoimmune disease models.A guidebook. Academic Press, San Diego, 1994, pp. 147-159.
10. Elias D., Reshef T., Birk O.S., van der Zee R., Walker M.D., Cohen I.R.: Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. USA 88: 3088-3091, 1991.
11. Birk O.S., Elias D., Weiss A.S., Rosen A., van der Zee R., Walker M.D., Cohen I.R.: NOD mouse diabetes: The ubiquitous mouse hsp60 is a beta-cell antigen of autoimmune T cells. J. Autoimmunity 9: 159-166, 1996.
12. Elias D., Prigozin H., Polak N., Rapoport M., Lohse A., Cohen I.R.: Autoimmune diabetes induced by the beta-cell toxin streptozotocin. Immunity to the 60KDa heat shock protein and to insulin. Diabetes 43: 992-998, 1994.
13. Elias D., Marcus H., Reshef T., Ablamunits V., Cohen I.R.: Induction of diabetes in standard mice by immunization to the p277 peptide of a 60KDa heat shock protein. Eur. J. Immunol. 25: 2851-2857, 1995.
14. Elias D., Cohen I.R.: Peptide therapy for diabetes in NOD mice. Lancet 343: 704-706, 1994.
15. Elias D., Cohen I.R.: Treatment of autoimmune diabetes in NOD mice. Diabetes 44: 1132-1138, 1995
16. Birk O.S., Douek D.C., Elias D., Takacs K., Dewchand H., Gur S.L., Walker M.D., van der Zee R., Cohen I.R., Altmann DM. The role of hsp60 in autoimmune diabetes: Analysis in a transgenic model. Proc. Natl. Acad. Sci. USA 93: 1032-1037, 1996.
17. Elias D., Cohen I.R.: The hsp60 peptide p277 arrests the autoimmune diabetes induced by the toxin streptozotocin, Diabetes in press.
18. Elias D., Melin A., Birk O.S., Carmi P., Könen-Waisman S., Cohen I.R.: Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and down-regulates autoimmunity to various β-cell antigens. submitted for publication.
19. Tisch R., Yand X.D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O.: Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice Nature 366: 72-75, 1993.
20. Tisch R., McDevitt H.: Insulin-dependent diabetes mellitus. Cell 85: 291-297, 1996.
21. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V.: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes Nature 366: 69-72, 1993.
22. Zhang Z.J., Davidson L., Eisenbarth G.S., Weiner H.L.: Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA 88: 10252-10256, 1991.
23. Cohen I.R., Young D.B.: Autoimmunity. microbial immunity and the immunological homunculus. Immunol Today 12: 105-110, 1991.
24. Cohen I.R.: The cognitive principle challenges clonal selection. Immunol. Today 13: 441-444, 1992.
25. Cohen I.R.: The cognitive paradigm and the immunological homunculus. Immunol. Today 13: 490-494, 1992.
26. Cohen I.R.: Treatment of autoimmune disease: To activate or to deactivate? Chem. Immunol. 60: 150-160, 1995.
27. Mahon J.L., Dupré J., Stiller C.R.: Lessons learned from the use of cyclosporin for insulin-dependent diabetes mellitus. The case for immunotherapy for insulin-dependent diabetics having residual secretion. Ann. NY Acad. Sci. 696: 351-363, 1993.
28. Cohen I.R.: Lanauage, meaning and the immune system. Israel J. Med. Sci. 31: 36-37, 1995.